BYSI
$1.79
Post-MarketAs of Mar 17, 8:00 PM UTC
BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on the development of cancer therapies.
Intraday
Custom Range:to
No data available for this range. Intraday data may be limited by the exchange.
Recent News
Here's Why We're Watching BeyondSpring's (NASDAQ:BYSI) Cash Burn Situation
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Can BeyondSpring (NASDAQ:BYSI) Afford To Invest In Growth?
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...